Guardant Health (GH)

Guardant Health (GH) Stock Price & Analysis


GH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$24.63 - $78.34
Previous Close$31.48
Average Volume (3M)1.62M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$958.04M
Total Debt (Recent Filing)$1.37B
Price to Earnings (P/E)-5.3
Next EarningsFeb 22, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-5.93
Shares Outstanding102,436,169
Standard Deviation0.17
10 Day Avg. Volume1,855,870
30 Day Avg. Volume1,621,761
Price to Book (P/B)21.48
Price to Sales (P/S)10.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-11.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside108.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Guardant Health’s price range in the past 12 months?
Guardant Health lowest stock price was $24.63 and its highest was $78.34 in the past 12 months.
    What is Guardant Health’s market cap?
    Currently, no data Available
    When is Guardant Health’s upcoming earnings report date?
    Guardant Health’s upcoming earnings report date is Feb 22, 2023 which is in 25 days.
      How were Guardant Health’s earnings last quarter?
      Guardant Health released its earnings results on Nov 03, 2022. The company reported -$1.58 earnings per share for the quarter, missing the consensus estimate of -$1.281 by -$0.299.
        Is Guardant Health overvalued?
        According to Wall Street analysts Guardant Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Guardant Health pay dividends?
          Guardant Health does not currently pay dividends.
          What is Guardant Health’s EPS estimate?
          Guardant Health’s EPS estimate is -$1.39.
            How many shares outstanding does Guardant Health have?
            Guardant Health has 102,436,170 shares outstanding.
              What happened to Guardant Health’s price movement after its last earnings report?
              Guardant Health reported an EPS of -$1.58 in its last earnings report, missing expectations of -$1.281. Following the earnings report the stock price went up 4.928%.
                Which hedge fund is a major shareholder of Guardant Health?
                Among the largest hedge funds holding Guardant Health’s share is Viking Global Investors LP. It holds Guardant Health’s shares valued at 206M.


                  Guardant Health Stock Smart Score

                  The Guardant Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Guardant Health

                  Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Signify Health
                  Option Care Health
                  AMN Healthcare Services
                  LHC Group

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis